Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro

Colorectal cancer (CRC) is the third most common cause of cancer-related morbidity worldwide, with an estimated of 1.85 million new cases and 850,000 deaths every year. Nevertheless, the current treatment regimens for CRC have many disadvantages, including toxicities and off-targeted side effects. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Mingjing, Tan, Jincheng, Chen, Hui, Shi, Zhiqiang, Kwan, Hiu-Yee, Su, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432182/
https://www.ncbi.nlm.nih.gov/pubmed/37593607
http://dx.doi.org/10.1016/j.heliyon.2023.e18488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432182/
https://www.ncbi.nlm.nih.gov/pubmed/37593607
http://dx.doi.org/10.1016/j.heliyon.2023.e18488

Ejemplares similares